Study on medication rule and action mechanism of coronary heart disease complicated with depression based on data mining and network pharmacology
LI Dongfang1 HUANG Lexi2 HOU Jiqiu1 LI Yan3 ZHAO Haibin1#br#
1.Dongfang Hospital of Beijing University of Chinese Medicine, Beijing 100078, China;
2.Zhejiang Province Hospital of Traditional Chinese Medicine, Zhejiang Province, Hangzhou 310003, China;
3.Beijing Fengtai Integrated Hospital of Traditional Chinese and Western Medicine, Beijing 100072, China
Abstract：Objective To analyze the medication rules of traditional Chinese medicine in the treatment of coronary heart disease complicated with depression by data mining, and to explore the potential mechanism of the core drugs. Methods CNKI, Wanfang Data, VIP, and China Biomedical Literature Service System were searched from January 2001 to July 2021 on the literature on the treatment of coronary heart disease complicated by depression with traditional Chinese medicine, the prescription database, was built and the traditional Chinese medicine inheritance assistance platform software was used to analyze the medication rules of prescriptions. The BATMAN-TCM traditional Chinese medicine analysis software was further used to analyze the genome encyclopedia pathway of the core drug compatibility to reveal the potential mechanism of action. Results A total of 70 prescriptions were included, involving 108 traditional Chinese medicines. The top six prescriptions were Bupleurum, Baishao, Chuanxiong, Salvia, Poria, and Suanzaoren. The four qi of the drug were mainly warm, and the five flavors were mostly bitter, acrid, and sweet. Eventually evolved to get eight new prescriptions. BATMAN-TCM analysis showed that there were 33 diseases with ≥four enriched targets in the combination of Bupleurum, Baishao, Chuanxiong, Poria, and Suanzaoren, and there were 37 biological pathways. Its mechanism of action might be through transient receptor potential channel, calcium signaling pathway, and cyclic guanosine monophosphate-protein kinase G signaling pathway in the treatment of coronary heart disease complicated with depression. Conclusion The combination of traditional Chinese medicine inheritance platform and network pharmacology is used to conduct data mining on the prescription rules and potential mechanism of Chinese medicine in the treatment of coronary heart disease complicated with depression, which can provide reference for clinical treatment and basic research of the disease.
李东方1 黄乐曦2 侯季秋1 李艳3 赵海滨1. 基于数据挖掘和网络药理学探讨冠心病合并抑郁用药规律和作用机制[J]. 中国医药导报, 2022, 19(22): 13-19.
LI Dongfang1 HUANG Lexi2 HOU Jiqiu1 LI Yan3 ZHAO Haibin1. Study on medication rule and action mechanism of coronary heart disease complicated with depression based on data mining and network pharmacology. 中国医药导报, 2022, 19(22): 13-19.
[1] 胡大一.心血管疾病和精神心理障碍的综合管理－“双心医学”模式的探索[J].中国临床医生，2006，34（5）：2-3.
[2] Song X，Song J，Shao M，et al. Depression predicts the risk of adverse events after percutaneous coronary intervention: a meta-analysis [J]. J Affect Disord，2020，266：158-164.
[3] Ren Y，Yang H，Browning C，et al. Prevalence of depression in coronary heart disease in China: a systematic review and meta-analysis [J]. Chin Med J（Engl），2014，127（16）：2991-2998.
[4] 刘安邦，马欢，耿庆山，等.冠心病合并抑郁症的研究进展[J].中国临床新医学，2021，14（2）：205-208.
[5] 刘畅，张米镎，寇兰俊，等.冠心病合并焦虑抑郁的中西医治疗进展[J].中西医结合心脑血管病杂志，2019，17（11）：1658-1660.
[6] 张寒芳，王恒和.基于现代文献分析冠心病合并焦虑抑郁用药规律[J].内蒙古中医药，2020，39（9）：160.
[7] 王颖，郭志，王琪，等.中医辨证治疗冠心病合并抑郁症的疗效观察[J].中医药导报，2018，24（10）：74-77.
[8] 刘昭文，姚羽，于慧兰，等.基于数据挖掘分析中药治疗糖尿病神经源性膀胱的用药规律[J].中国医药导报，2021， 18（12）：174.
[9] 国际心脏病学会和协会，世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志，1981，9（1）：75.
[10] 中华医学会精神科分会.中国精神障碍分类与诊断标准（CCMD-3）[M].3版.济南：山东科学技术出版社，2001：28.
[11] 国家药典委员会.中华人民共和国药典[S].一部.北京：中国医药科技出版社，2020：1902.
[12] 钟赣生.中药学[M].北京：中国中医药出版社，2016：482.
[13] 刘括，孙殿钦，廖星，等.随机对照试验偏倚风险评估工具2.0修订版解读[J].中国循证心血管医学杂志，2019， 11（3）：284-291.
[14] Liu Z，Guo F，Wang Y，et al. BATMAN-TCM：a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine [J]. Sci Rep，2016，6（12）：21146.
[15] 白明，刘保松，彭孟凡，等.基于数据挖掘和网络药理学的2型糖尿病用药规律及机制分析[J].中国实验方剂学杂志，2019，25（9）：182-188.
[16] 唐卓然，侯季秋，陈雅丽，等.双心诊疗干预心肌梗死后抑郁理论探源[J].环球中医药，2021，14（1）：32-34.
[17] 吴丹，高耀，向欢，等.基于网络药理学的柴胡抗抑郁作用研究[J].药学学报，2018，53（2）：210-219.
[18] 张洪财，王文姌，陈雁雁.柴胡-白芍对抑郁大鼠海马神经递质的影响[J].哈尔滨商业大学学报（自然科学版），2017，33（5）：519-522.
[19] 刘凌云.温度感受器和触觉感受器的发现[J].生物化学与生物物理进展，2021（12）：1381-1391.
[20] 谢洪祥.TRPA1在冠心病患者外周血单核细胞中的表达与冠脉病变程度的相关性研究[D].成都：成都医学院，2018.
[21] Yoshida A，Furube E，Mannari T，et al. TRPV1 is crucial for proinflammatory STAT3 signaling and thermoregulation-associated pathways in the brain inflammation [J]. Sci Rep，2016，6：26088.
[22] 王金梦，杨玉，刘星玥，等.基于信号通路的中药抗抑郁症作用机制研究进展[J].中华中医药学刊，2021，39（1）：116.
[23] 董丹红，庞玺倬，李琳.PKG信号通路在ACS患者PCI术后血管内皮损伤中的作用[J].昆明医科大学学报，2020， 41（8）：27-32.
[24] 王景霞，张建军，李伟，等.芍药苷抗抑郁作用与NO/cGMP通路相关性研究[J].中药与临床，2012，3（1）：27-28.
[25] Yuan Z，Miyoshi T，Bao Y，et al. Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility [J]. Am J Physiol Herat Circ Physiol，2009， 296（5）：H1336-H1343.
[26] 叶招娣，刘中勇.基于网络药理学探讨颠倒木金散治疗冠心病的分子机制研究[J].中医药通报，2021，20（2）：32-37.
[27] 曹宝国，刘惠娟，王新舜，等.竭香定痛胶囊治疗冠心病网络药理学作用机制研究[J].中国当代医药，2022，29（1）：18-22，封4.
[28] Hell JW. CaMKⅡ：Claiming Center Stage in Postsynaptic Function and Organizaton [J]. Neu Ron，2014，81（2）：249-265.
京公网安备 11010502046598号